Camden Carmichael

Camden joined Health Advances in 2023 and brings experience in portfolio strategy and indication prioritization, competitive landscape assessment, product launch strategy, and commercial due diligence across the biopharma, precision medicine, and clinical diagnostic sectors. He has expertise across disease areas with a special interest in precision oncology.

Prior to joining Health Advances Camden was a research associate at the ADA Forsyth Institute and a Summer Research Fellow at Cincinnati Children’s Hospital. 

Camden graduated summa cum laude with a BS in Microbiology from NC State University.